Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen

BMC Biochemistry

Volumn 12, Issue 1, 2011, Pages

  Brauer, Rena ^a,b   Beck, Inken M ^a,b,c   Roderfeld, Martin ^d   Roeb, Elke ^d   Sedlacek, Radislav ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^c INSTITUTE OF BIOTECHNOLOGY   (Czech Republic)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; MATRIX METALLOPROTEINASE 19; PLASMINOGEN; PROTEIN KINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; ANGIOGENESIS INHIBITOR; GLUTATHIONE TRANSFERASE; MATRIX METALLOPROTEINASE; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

ANGIOGENESIS; ARTICLE; CAPILLARY ENDOTHELIUM; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; CAPILLARY; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME SPECIFICITY; GENETICS; METABOLISM; PHOSPHORYLATION; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANGIOSTATINS; CAPILLARIES; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUTATHIONE TRANSFERASE; HUMANS; MATRIX METALLOPROTEINASES, SECRETED; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PLASMINOGEN; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 79960572812     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-12-38     Document Type: Article

References (41)

1. Angiogenesis. Folkman J, Annu Rev Med 2006 57 1 18 10.1146/annurev.med. 57.121304.131306 16409133 (Pubitemid 43261975)
2. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J, Cell 1994 79 2 315 328 10.1016/0092-8674(94)90200-3 7525077 (Pubitemid 24324921)
3. Angiostatin induces and sustains dormancy of human primary tumors in mice. O'Reilly MS, Holmgren L, Chen C, Folkman J, Nat Med 1996 2 6 689 692 10.1038/nm0696-689 8640562 (Pubitemid 26191958)
4. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells. Stathakis P, Fitzgerald M, Matthias LJ, Chesterman CN, Hogg PJ, J Biol Chem 1997 272 33 20641 20645 10.1074/jbc.272.33.20641 9252380 (Pubitemid 27355624)
5. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. Cao Y, Ji RW, Davidson D, Schaller J, Marti D, Sohndel S, McCance SG, O'Reilly MS, Llinas M, Folkman J, J Biol Chem 1996 271 46 29461 29467 10.1074/jbc.271.46.29461 8910613 (Pubitemid 26382666)
6. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Cao R, Wu HL, Veitonmaki N, Linden P, Farnebo J, Shi GY, Cao Y, Proc Natl Acad Sci USA 1999 96 10 5728 5733 10.1073/pnas.96.10.5728 10318952 (Pubitemid 29234686)
7. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. Heidtmann HH, Nettelbeck DM, Mingels A, Jager R, Welker HG, Kontermann RE, Br J Cancer 1999 81 8 1269 1273 10.1038/sj.bjc.6692167 10604721
8. Angiostatin generation by cathepsin D secreted by human prostate carcinoma cells. Morikawa W, Yamamoto K, Ishikawa S, Takemoto S, Ono M, Fukushi J, Naito S, Nozaki C, Iwanaga S, Kuwano M, J Biol Chem 2000 275 49 38912 38920 10986284 (Pubitemid 32009230)
9. Matrix metalloproteinases generate angiostatin: effects on neovascularization. Cornelius LA, Nehring LC, Harding E, Bolanowski M, Welgus HG, Kobayashi DK, Pierce RA, Shapiro SD, J Immunol 1998 161 12 6845 6852 9862716 (Pubitemid 28562229)
10. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). Patterson BC, Sang QA, J Biol Chem 1997 272 46 28823 28825 10.1074/jbc.272.46.28823 9360944 (Pubitemid 27498157)
11. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, Folkman J, Moses MA, J Biol Chem 1999 274 41 29568 29571 10.1074/jbc.274.41.29568 10506224 (Pubitemid 29477133)
12. Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis. Sedlacek R, Mauch S, Kolb B, Schatzlein C, Eibel H, Peter HH, Schmitt J, Krawinkel U, Immunobiology 1998 198 4 408 423 9562866 (Pubitemid 28098486)
13. Identification of MMP-18, a putative novel human matrix metalloproteinase. Cossins J, Dudgeon TJ, Catlin G, Gearing AJ, Clements JM, Biochem Biophys Res Commun 1996 228 2 494 498 10.1006/bbrc.1996.1688 8920941 (Pubitemid 26396101)
14. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. Pendas AM, Knauper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G, Lopez-Otin C, J Biol Chem 1997 272 7 4281 4286 10.1074/jbc.272.7.4281 9020145 (Pubitemid 27078499)
15. The murine ortholog of matrix metalloproteinase 19: its cloning, gene organization, and expression. Mueller MS, Harnasch M, Kolb C, Kusch J, Sadowski T, Sedlacek R, Gene 2000 256 1-2 101 111 10.1016/S0378-1119(00)00369-3 11054540
16. Structure of the human MMP-19 gene. Mueller MS, Mauch S, Sedlacek R, Gene 2000 252 1-2 27 37 10.1016/S0378-1119(00)00236-5 10903435 (Pubitemid 30618810)
17. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). Stracke JO, Fosang AJ, Last K, Mercuri FA, Pendas AM, Llano E, Perris R, Di Cesare PE, Murphy G, Knauper V, FEBS Lett 2000 478 1-2 52 56 10.1016/S0014-5793(00)01819-6 10922468 (Pubitemid 30462257)
18. The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient. Kolb C, Mauch S, Peter HH, Krawinkel U, Sedlacek R, Immunol Lett 1997 57 1-3 83 88 10.1016/S0165-2478(97)00057-6 9232430 (Pubitemid 27319317)
19. Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium. Kolb C, Mauch S, Krawinkel U, Sedlacek R, Exp Cell Res 1999 250 1 122 130 10.1006/excr.1999.4493 10388526 (Pubitemid 29391576)
20. Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface. Mauch S, Kolb C, Kolb B, Sadowski T, Sedlacek R, J Immunol 2002 168 3 1244 1251 11801661 (Pubitemid 34094491)
21. MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. Djonov V, Hogger K, Sedlacek R, Laissue J, Draeger A, J Pathol 2001 195 2 147 155 10.1002/path.927 11592092 (Pubitemid 32899022)
22. Matrix metalloproteinase-19 expression in normal and diseased skin: dysregulation by epidermal proliferation. Sadowski T, Dietrich S, Muller M, Havlickova B, Schunck M, Proksch E, Muller MS, Sedlacek R, J Invest Dermatol 2003 121 5 989 996 10.1046/j.1523-1747.2003.12526.x 14708597 (Pubitemid 37430964)
23. Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Sadowski T, Dietrich S, Koschinsky F, Sedlacek R, Mol Biol Cell 2003 14 11 4569 4580 10.1091/mbc.E03-01-0009 12937269 (Pubitemid 37444656)
24. Activity of MMP-19 inhibits capillary-like formation due to processing of nidogen-1. Titz B, Dietrich S, Sadowski T, Beck C, Petersen A, Sedlacek R, Cell Mol Life Sci 2004 61 14 1826 1833 15241558 (Pubitemid 39044260)
25. Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration. Sadowski T, Dietrich S, Koschinsky F, Ludwig A, Proksch E, Titz B, Sedlacek R, Cell Mol Life Sci 2005 62 7-8 870 880 10.1007/s00018-005-4478-8 15868410 (Pubitemid 40655634)
26. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. Stracke JO, Hutton M, Stewart M, Pendas AM, Smith B, Lopez-Otin C, Murphy G, Knauper V, J Biol Chem 2000 275 20 14809 14816 10.1074/jbc.275.20.14809 10809722 (Pubitemid 30337192)
27. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells. Wajih N, Sane DC, Blood 2003 101 5 1857 1863 10.1182/blood-2002-02-0582 12406896 (Pubitemid 36237585)
28. Recombinant kringle 5 from plasminogen antagonises hepatocyte growth factor-mediated signalling. Ansell PJ, Zhang H, Davidson DJ, Harlan JE, Xue J, Brodjian S, Lesniewski R, McKeegan E, Eur J Cancer 46 5 966 973
29. Molecular cloning and characterization of a full-length cDNA clone for human plasminogen. Forsgren M, Raden B, Israelsson M, Larsson K, Heden LO, FEBS Lett 1987 213 2 254 260 10.1016/0014-5793(87)81501-6 3030813 (Pubitemid 17043905)
30. p22 is a novel plasminogen fragment with antiangiogenic activity. Kwon M, Yoon CS, Fitzpatrick S, Kassam G, Graham KS, Young MK, Waisman DM, Biochemistry 2001 40 44 13246 13253 10.1021/bi0113420 11683633 (Pubitemid 33043539)
31. Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors. Kassam G, Kwon M, Yoon CS, Graham KS, Young MK, Gluck S, Waisman DM, J Biol Chem 2001 276 12 8924 8933 10.1074/jbc.M009071200 11114303
32. Phosphoglycerate kinase acts in tumour angiogenesis as a disulphide reductase. Lay AJ, Jiang XM, Kisker O, Flynn E, Underwood A, Condron R, Hogg PJ, Nature 2000 408 6814 869 873 10.1038/35048596 11130727 (Pubitemid 32016098)
33. Pericellular proteases in angiogenesis and vasculogenesis. van Hinsbergh VW, Engelse MA, Quax PH, Arterioscler Thromb Vasc Biol 2006 26 4 716 728 10.1161/01.ATV.0000209518.58252.17 16469948 (Pubitemid 43732143)
34. New functions for the matrix metalloproteinases in cancer progression. Egeblad M, Werb Z, Nat Rev Cancer 2002 2 3 161 174 10.1038/nrc745 11990853 (Pubitemid 37328786)
35. Basement membranes: structure, assembly and role in tumour angiogenesis. Kalluri R, Nat Rev Cancer 2003 3 6 422 433 10.1038/nrc1094 12778132 (Pubitemid 37328846)
36. Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma. Chan KC, Ko JM, Lung HL, Sedlacek R, Zhang ZF, Luo DZ, Feng ZB, Chen S, Chen H, Chan KW, et al. Int J Cancer
37. Earlier onset of tumoral angiogenesis in matrix metalloproteinase-19- deficient mice. Jost M, Folgueras AR, Frerart F, Pendas AM, Blacher S, Houard X, Berndt S, Munaut C, Cataldo D, Alvarez J, et al. Cancer Res 2006 66 10 5234 5241 10.1158/0008-5472.CAN-05-4315 16707448 (Pubitemid 43844947)
38. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Nakagami H, Morishita R, Yamamoto K, Taniyama Y, Aoki M, Matsumoto K, Nakamura T, Kaneda Y, Horiuchi M, Ogihara T, Hypertension 2001 37 2 Part 2 581 586 11230338 (Pubitemid 32199031)
39. Separation of copurifying GroEL from glutathione-S-transferase fusion proteins. Rohman M, Harrison-Lavoie KJ, Protein Expr Purif 2000 20 1 45 47 10.1006/prep.2000.1271 11035949
40. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. Kubota Y, Kleinman HK, Martin GR, Lawley TJ, J Cell Biol 1988 107 4 1589 1598 10.1083/jcb.107.4.1589 3049626
41. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Donovan D, Brown NJ, Bishop ET, Lewis CE, Angiogenesis 2001 4 2 113 121 10.1023/A:1012218401036 11806243 (Pubitemid 34032697)